ReviewJournal of hand surgery global online2026
What's New in Wide-Awake Local Anesthesia No Tourniquet (WALANT) Hand Surgery?
Review in Journal of hand surgery global online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wide-awake local anesthesia no tourniquet (WALANT) has evolved from a novel technique to an increasingly adopted anesthetic strategy in hand surgery. In the post-coronavirus disease (COVID)-19 era, there has been a marked expansion in WALANT-related literature, necessitating synthesis of contemporary evidence to guide clinical practice. This narrative review examines recent WALANT studies organized into six thematic domains: comparative trials versus traditional anesthesia, use in the pediatric population, patient satisfaction and experience, environmental impact, cost comparison and value-based care, and applications beyond the hand and wrist. Comparative studies consistently demonstrate that WALANT provides noninferior functional outcomes and complication rates relative to regional and general anesthesia, with improved intraoperative pain and similar early postoperative pain. Pediatric data support feasibility and high satisfaction in appropriately selected patients, particularly adolescents. Patient satisfaction is uniformly high, with strong willingness to repeat WALANT procedures. WALANT pathways also reduce solid waste and carbon emissions, particularly when procedures are performed outside the main operating room. Cost analyses demonstrate substantial savings driven by decreased anesthesia use and site-of-service optimization. Expanding indications now include proximal upper extremity procedures and select nonupper extremity surgeries, reflecting increasing surgeon experience and confidence. WALANT represents a mature, evidence-supported care pathway that aligns clinical outcomes with patient-centered experience, environmental sustainability, and cost efficiency. Its greatest impact is realized when integrated into procedure room-based workflows with careful patient selection and standardized technique. Future efforts should focus on refining indications, optimizing patient experience, and expanding scalable implementation across diverse practice settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.